PRInted Symbiotic Materials as a dynamic platform for Living Tissues production

PRISM-LT aims to develop a flexible bioprinting platform using hybrid living materials to enhance stem cell differentiation with engineered helper cells for biomedical and food applications.

Subsidie
€ 2.805.403
2022

Projectdetails

Introduction

The PRISM-LT aims at creating a flexible platform for next generation living tissue manufacturing based on Hybrid Living Materials.

Bio-Ink Design

We plan to design a novel bio-ink where stem cells are integrated in a support matrix enriched with engineered helper cells (either bacteria or yeasts, depending on the application and requirements).

Bioprinting Process

Tuning the operational parameters of the bioprinting process, we will cast down the material controlling the mechanical properties of each voxel. This will allow us to achieve a 3D patterned structure where stem cells are locally induced to initiate their differentiation towards different lineages.

Stem Cell and Helper Cell Interaction

As far as stem cells proliferate, the helpers remain in a quiescent state. However, when the stem cells get stimulated by the local (printed) mechanics and enter a differentiation pathway, they start secreting a pool of lineage-specific metabolites.

The helper cells are designed to:

  1. Sense these early markers of differentiation.
  2. Respond by producing in-situ the corresponding growth factors, providing the relevant chemical guidance.

Helper cells within the platform amplify the initial lineage commitment in each area and dynamically sustain differentiation on a longer term.

Project Implementation

During the project, we will implement this strategy and develop two independent symbiotic materials, targeting biomedical and food applications, respectively.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.805.403
Totale projectbegroting€ 2.805.403

Tijdlijn

Startdatum1-11-2022
Einddatum31-10-2027
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • IN SRL IMPRESA SOCIALEpenvoerder
  • CHALMERS TEKNISKA HOGSKOLA AB
  • STICHTING RADBOUD UNIVERSITEIT
  • BICO GROUP AB
  • CELLINK BIOPRINTING AB
  • UNIVERSIDADE DE AVEIRO
  • UNIVERSITY OF GLASGOW

Land(en)

ItalySwedenNetherlandsPortugalUnited Kingdom

Vergelijkbare projecten binnen EIC Pathfinder

EIC Pathfinder

Next Generation 3D Tissue Models: Bio-Hybrid Hierarchical Organoid-Synthetic Tissues (Bio-HhOST) Comprised of Live and Artificial Cells.

Bio-HhOST aims to create bio-hybrid materials with living and artificial cells for dynamic communication, enhancing tissue modeling and reducing animal use in drug research.

€ 1.225.468
EIC Pathfinder

Living Therapeutic and Regenerative Materials with Specialised Advanced Layers

Developing skin-inspired engineered living materials with sensing and regenerative functions for therapeutic and protective applications through multicellular consortia and genetic control.

€ 2.856.441
EIC Pathfinder

High-throughput ultrasound-based volumetric 3D printing for tissue engineering

SONOCRAFT aims to revolutionize myocardial cell construct bioprinting by combining rapid volumetric printing with ultrasonic manipulation to create functional cardiac models for drug testing and disease research.

€ 2.999.625
EIC Pathfinder

building vascular networks and Blood-Brain-Barriers through a Biomimetic manufacturing Technology for the fabrication of Human tissues and ORgans

THOR aims to revolutionize tissue engineering by creating patient-specific, fully functional human tissues using bioinspired mini-robots, eliminating the need for organ transplants.

€ 3.994.150

Vergelijkbare projecten uit andere regelingen

ERC Proof of...

A novel support material for 3D bioprinting and post-printing tissue growth: Print and Grow

The "Print and Grow" project aims to enhance 3D bioprinting stability and viability of tissue constructs through a novel microgel support, optimizing for diverse tissue types and in vivo applications.

€ 150.000
ERC Proof of...

Human based bioinks to engineer physiologically relevant tissues

HumanINK aims to validate human-based bioinks for 3D bioprinting, creating advanced cell culture environments to enhance drug development and reduce reliance on animal testing.

€ 150.000
ERC Proof of...

Bioactive reinforcing bioink for hybrid bioprinting of implantable bone

The project aims to develop 'BioForceInk,' a bioactive bioink for hybrid 3D bioprinting of vascularized bone implants, enhancing mechanical strength and biological functionality for clinical applications.

€ 150.000
ERC Starting...

Jam with the flow: Microgel-based (bio)inks that assemble during printing

Developing microgel-based materials for extrusion-based 3D printing to create stable, heterogeneous scaffolds with precise control over local properties for biomedical applications.

€ 2.075.000
ERC Starting...

4D bioprinting shape-morphing tissues using phototunable supramolecular hydrogels

morphoPRINT aims to develop a dynamic hydrogel platform for bioprinted tissues that enables programmable shape-morphing, facilitating the creation of functional organs through controlled volumetric growth.

€ 1.499.906